Publications by authors named "Jason T Connor"

Claim this Profile
S
Simulation-Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies.
Chiara Micoli, Alessio Crippa, Jason T Connor, , Martin Eklund

Pharm Stat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory.
Thomas R Fleming, Janet Wittes, Mona Fiuzat, Michael R Bristow, Frank W Rockhold, Jason T Connor, Christopher O'Connor

JACC Heart Fail· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
Mark Yarchoan, Edward J Gane, Thomas U Marron, Renzo Perales-Linares, Jian Yan, Jason T Connor

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A template for the authoring of statistical analysis plans.
Gary Stevens, Shawn Dolley, Robin Mogg, Jason T Connor

Contemp Clin Trials Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.
Alessio Crippa, Bram De Laere, Andrea Discacciati, Berit Larsson, Jason T Connor

Trials· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
James M Chamberlain, Jaideep Kapur, Shlomo Shinnar, Jordan Elm, Maija Holsti, Jason T Connor

Lancet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Carter et al.
Martin Eklund, Kristine Broglio, Christina Yau, Jason T Connor, Allison Stover Fiscalini

JNCI Cancer Spectr· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.
Christopher C Butler, Alike W van der Velden, Emily Bongard, Benjamin R Saville, Jane Holmes, Jason T Connor

Lancet· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
Jaideep Kapur, Jordan Elm, James M Chamberlain, William Barsan, James Cloyd, Jason T Connor

N Engl J Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches.
Martin Eklund, Kristine Broglio, Christina Yau, Jason T Connor, Allison Stover Fiscalini

JNCI Cancer Spectr· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answering patient-centred questions efficiently: response-adaptive platform trials in primary care.
Christopher C Butler, Jason T Connor, Roger J Lewis, Kristine Broglio, Benjamin R Saville

Br J Gen Pract· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (afternoon panel discussion).
Jason T Connor, Angela DeMichele, Janet Wittes

Clin Trials· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.
Jeffrey Glassberg, Caterina Minnitti, Caroline Cromwell, Lawrence Cytryn, Thomas Kraus, Jason T Connor

Am J Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution.
Bryan R Luce, Jason T Connor, Kristine R Broglio, C Daniel Mullins, K Jack Ishak

Ann Intern Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation of various randomization strategies for a clinical trial in sickle cell disease.
William J Meurer, Jason T Connor, Jeffrey Glassberg

Hematology· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population.
Melanie Quintana, Daniel H Li, Tina M Albertson, Jason T Connor

Contemp Clin Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process.
Kert Viele, Jason T Connor

JAMA· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design.
Randall J Lee, Dhanunjaya Lakkireddy, Suneet Mittal, Christopher Ellis, Jason T Connor

Am Heart J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The platform trial: an efficient strategy for evaluating multiple treatments.
Scott M Berry, Jason T Connor, Roger J Lewis

JAMA· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study.
Jason T Connor, Kristine R Broglio, Valerie Durkalski, William J Meurer, Karen C Johnston

Trials· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not too big, not too small: a goldilocks approach to sample size selection.
Kristine R Broglio, Jason T Connor, Scott M Berry

J Biopharm Stat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of Bayesian predictive probabilities for interim monitoring of clinical trials.
Benjamin R Saville, Jason T Connor, Gregory D Ayers, JoAnn Alvarez

Clin Trials· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer.
Christian P Pavlovich, Toby C Cornish, Jeffrey K Mullins, Joel Fradin, Lynda Z Mettee, Jason T Connor

Urol Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.
Jason T Connor, Bryan R Luce, Kristine R Broglio, K Jack Ishak, C Daniel Mullins

Clin Trials· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.
Jason T Connor, Jordan J Elm, Kristine R Broglio,

J Clin Epidemiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis